methamphetamine has been researched along with Heart Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Brazeau, DA; Chavva, H; Dague, A; Denvir, J; Rorabaugh, BR | 1 |
| Berry, GJ; de Jesus Perez, V; Doyle, RL; Greuenwald, P; Hedlin, H; Hsi, A; Jorden, M; Kawut, SM; Kudelko, K; Liu, J; Rabinovitch, M; Rupp, A; Segal, JI; Sweatt, AJ; Tuder, R; Wilson, DM; Zamanian, RT | 1 |
| Kuo, CH; Lee, SD; Liou, CM; Ting, H; Tsai, SC; Williams, T | 1 |
| Janardhanan, R; Kannan, A | 1 |
| Richards, JR | 1 |
| Cunningham, N; MacIsaac, AI; Paratz, ED | 1 |
| MacIsaac, AI; Paratz, ED; Scarlato, RM; Sherwen, AK; Zhao, J | 1 |
| Bosch, X; Ortega-Paz, L; Pujol-López, M; Roqué, M | 1 |
| Larson, DF; Watson, RR; Yu, Q | 1 |
| Baumann, MH; Rothman, RB; Zolkowska, D | 1 |
| Corkery, JM; Cuffolo, G; Schifano, F | 1 |
| Gold, MS; Goldberger, BA; Graham, NA; Kobeissy, FH; Pepine, CJ | 1 |
| Darke, S; Duflou, J; Kaye, S; McKetin, R | 1 |
| Hongcheng, B; Islam, MN; Kawaguchi, N; Kuroki, H; Ogura, Y; Onishi, S; Wakasugi, C | 1 |
3 review(s) available for methamphetamine and Heart Diseases
| Article | Year |
|---|---|
Heart disease, methamphetamine and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Heart Diseases; Humans; Immune System; Methamphetamine; Substance-Related Disorders | 2003 |
Smokable ("ice", "crystal meth") and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK.
Topics: Administration, Oral; Amphetamines; Australia; Biological Availability; Canada; Central Nervous System Stimulants; Crime; European Union; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Injections; Legislation, Drug; Male; Mental Disorders; Methamphetamine; Prevalence; Smoking; South Africa; Substance-Related Disorders; Tooth Diseases; United Kingdom; United States | 2007 |
Major physical and psychological harms of methamphetamine use.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Heart Diseases; Humans; Illicit Drugs; Methamphetamine; Self-Injurious Behavior; Suicide | 2008 |
1 trial(s) available for methamphetamine and Heart Diseases
| Article | Year |
|---|---|
Is an Abnormal ECG Just the Tip of the ICE-berg? Examining the Utility of Electrocardiography in Detecting Methamphetamine-Induced Cardiac Pathology.
Topics: Adult; Amphetamine-Related Disorders; Echocardiography; Electrocardiography; Female; Heart Diseases; Humans; Male; Methamphetamine; Retrospective Studies | 2017 |
10 other study(ies) available for methamphetamine and Heart Diseases
| Article | Year |
|---|---|
Maternal use of methamphetamine induces sex-dependent changes in myocardial gene expression in adult offspring.
Topics: Adult; Adult Children; Child; Female; Gene Expression; Heart Diseases; Humans; Hydroxybutyrate Dehydrogenase; Male; Methamphetamine; Myocardium; Pregnancy; Prenatal Exposure Delayed Effects; Sex Factors | 2022 |
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
Topics: Adult; California; Causality; Central Nervous System Stimulants; Cohort Studies; Comorbidity; Female; Heart Diseases; Humans; Hypertension, Pulmonary; Male; Methamphetamine; Middle Aged; Prospective Studies; Sex Distribution | 2018 |
Chronic methamphetamine exposure induces cardiac fas-dependent and mitochondria-dependent apoptosis.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Central Nervous System Stimulants; fas Receptor; Fibrosis; Heart Diseases; Male; Methamphetamine; Mitochondria, Heart; Myocardium; Rats, Wistar; Signal Transduction; Time Factors | 2014 |
Methamphetamine Cardiotoxicity: Unique Presentation with Multiple Bi-Ventricular Thrombi.
Topics: Adult; Amphetamine-Related Disorders; Cardiotoxicity; Echocardiography; Heart Diseases; Heart Ventricles; Humans; Male; Methamphetamine; Pulmonary Embolism; Radiography; Thrombosis | 2016 |
Beta Blockers and the Cardiac Complications of Methamphetamine.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Dose-Response Relationship, Drug; Heart Diseases; Humans; Methamphetamine | 2017 |
Response to 'Beta-Blockers and The Cardiac Complications of Methamphetamines'.
Topics: Adrenergic beta-Antagonists; Heart Diseases; Humans; Methamphetamine | 2017 |
Severe Cardiac Complications of Shabu Use: An Emerging Drug in Europe.
Topics: Adult; Cardiotoxicity; Central Nervous System Stimulants; Female; Heart Diseases; Humans; Incidence; Male; Methamphetamine; Middle Aged; Philippines; Risk Factors; Survival Rate; Young Adult | 2017 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical | 2006 |
Speed, cocaine, and other psychostimulants death rates.
Topics: Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Heart Diseases; Humans; Methamphetamine | 2007 |
Cardiac lesions and their reversibility after long term administration of methamphetamine.
Topics: Animals; Heart; Heart Diseases; Male; Methamphetamine; Microscopy, Electron; Myocardium; Prospective Studies; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Sympathomimetics; Time Factors | 1995 |